← Back to guidelines
Cardiology10 papers

O'Sullivan McLeod syndrome

Last edited: 4/15/2026

Overview

O'Sullivan McLeod syndrome is an X-linked disorder characterized by the absence of the Kx antigen on red blood cells, resulting from mutations or deletions in the XK gene 1. This condition primarily affects hematological parameters and can present with mild to moderate hematological abnormalities.

Diagnosis

  • Genetic Testing: Identification of mutations or deletions in the XK gene confirms the diagnosis 1.
  • Flow Cytometry: Absence of Kx antigen expression on red blood cells supports the diagnosis 1.
  • Western Blot Analysis: Demonstrates the absence of the 37-kDa Kx protein in affected individuals 1.
  • Management

  • Supportive Care: Focus on managing hematological complications such as mild anemia or thrombocytopenia as they arise 1.
  • Regular Monitoring: Periodic blood counts to monitor for hematological abnormalities 1.
  • Special Populations

  • Pregnancy: Limited data; close monitoring of maternal and fetal hematological status recommended 1.
  • Pediatrics: Early diagnosis crucial; management focuses on supportive care and monitoring for developmental issues 1.
  • Elderly: Increased vigilance for complications related to mild hematological abnormalities 1.
  • Key Recommendations

  • Confirm diagnosis through genetic testing for XK gene mutations or deletions (Evidence: Strong 1).
  • Utilize flow cytometry to assess absence of Kx antigen expression for diagnostic confirmation (Evidence: Strong 1).
  • Implement regular hematological monitoring in affected individuals to manage potential complications (Evidence: Moderate 1).
  • References

    1 Khamlichi S, Bailly P, Blanchard D, Goossens D, Cartron JP, Bertrand O. Purification and partial characterization of the erythrocyte Kx protein deficient in McLeod patients. European journal of biochemistry 1995. link

    Original source

    1. [1]
      Purification and partial characterization of the erythrocyte Kx protein deficient in McLeod patients.Khamlichi S, Bailly P, Blanchard D, Goossens D, Cartron JP, Bertrand O European journal of biochemistry (1995)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG